Abstract:Chondrocytes proliferate and mature into hypertrophic chondrocytes. Vascular invasion into the cartilage occurs in the terminal hypertrophic chondrocyte layer, and terminal hypertrophic chondrocytes die by apoptosis or transdifferentiate into osteoblasts. Runx2 is essential for osteoblast differentiation and chondrocyte maturation. Runx2 -deficient mice are composed of cartilaginous skeletons and lack the vascular invasion into the cartilage. However, the requirement of Runx2 in the vascular invasion into the cartilage, mechanism of chondrocyte transdifferentiation to osteoblasts, and its significance in bone development remain to be elucidated. To investigate these points, we generated Runx2 fl/flCre mice, in which Runx2 was deleted in hypertrophic chondrocytes using Col10a1 Cre. Vascular invasion into the cartilage was similarly observed in Runx2 fl/fl and Runx2 fl/flCre mice. Vegfa expression was reduced in the terminal hypertrophic chondrocytes in Runx2 fl/flCre mice, but Vegfa was strongly expressed in osteoblasts in the bone collar, suggesting that Vegfa expression in bone collar osteoblasts is sufficient for vascular invasion into the cartilage. The apoptosis of terminal hypertrophic chondrocytes was increased and their transdifferentiation was interrupted in Runx2 fl/flCre mice, leading to lack of primary spongiosa and osteoblasts in the region at E16.5. The osteoblasts appeared in this region at E17.5 in the absence of transdifferentiation, and the number of osteoblasts and the formation of primary spongiosa, but not secondary spongiosa, reached to levels similar those in Runx2 fl/fl mice at birth. The bone structure and volume and all bone histomophometric parameters were similar between Runx2 fl/fl and Runx2 fl/flCre mice after 6 weeks of age. These findings indicate that Runx2 expression in terminal hypertrophic chondrocytes is not required for vascular invasion into the cartilage, but is for their survival and transdifferentiation into osteoblasts, and that the transdifferentiation is necessary for trabecular bone formation in embryonic and neonatal stages, but not for acquiring normal bone structure and volume in young and adult mice.

Functional Analyses Reveal the Essential Role of Sox6 and Runx2 in the Communication of Chondrocyte and Osteoblast

Runx3 Regulates Chondrocyte Phenotype by Controlling Multiple Genes Involved in Chondrocyte Proliferation and Differentiation

Advances in the Roles of Runt-Related Transcription Factor 2 in Skeletal Development and Differentiation of Mesenchymal Stem Cells

Runx1 Up-Regulates Chondrocyte to Osteoblast Lineage Commitment and Promotes Bone Formation by Enhancing Both Chondrogenesis and Osteogenesis.

Molecular Mechanism of Runx2-Dependent Bone Development

Molecular mechanism of osteochondroprogenitor fate determination during bone formation.

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

Bioinformatics Analysis Makes Revelation to Potential Properties on Regulation and Functions of Human Sox2

Advances in the Research of RUNX2

Genetic analysis of Runx2 function during intramembranous ossification

Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation

"A Friend Among Strangers" or the Ambiguous Roles of Runx2

Loss of Smad3-Mediated Negative Regulation of Runx2 Activity Leads to an Alteration in Cell Fate Determination

RUNX2 co-operates with EGR1 to regulate osteogenic differentiation through Htra1 enhancers.

FoxO3a cooperates with RUNX1 to promote chondrogenesis and terminal hypertrophic of the chondrogenic progenitor cells

Runx2, an inducer of osteoblast and chondrocyte differentiation

An Essential Role of Discoidin Domain Receptor 2 (DDR2) in Osteoblast Differentiation and Chondrocyte Maturation Via Modulation of Runx2 Activation

Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts

Research Advances in Sox Gene Family

Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development

Specific Residues of RUNX2 Are Obligatory for Formation of BMP2-Induced RUNX2-SMAD Complex to Promote Osteoblast Differentiation